Evaluation of the Safety and Effectiveness of an Extended Macular Vision Intraocular Lens (IOL) for Age-Related Macular Degeneration (AMD) in Everyday Clinical Practice - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluation of the Safety and Effectiveness of an Extended Macular Vision Intraocular Lens (IOL) for Age-Related Macular Degeneration (AMD) in Everyday Clinical Practice

  • By

  • Fritz H. Hengerer

  • Boris Stanzel

  • Jairo Hoyos-Chacon

  • Marta Suarez

  • Sebastian Beckers

  • Patrizia Busatto

  • Federico Badalà

  • December 23, 2025

Share

  • 1

    Age-related macular degeneration (AMD) is a leading cause of legal blindness, affecting millions globally and increasing the burden on healthcare systems.

  • 2

    The EyeMax Mono IOL is designed to improve image quality for AMD patients by optimizing vision at preferred retinal loci within 10° of eccentricity.

  • 3

    This multicenter study evaluated the safety and efficacy of the EyeMax Mono IOL in AMD patients undergoing cataract surgery.

  • 4

    Outcome measures included intraoperative complications and changes in corrected distance and near visual acuity before and after surgery.

  • 5

    The EyeMax Mono IOL features wavefront-optimized optics, providing a larger retinal area of focus compared to standard monofocal IOLs.

Original Source(s)

Related Content